Inovio Pharmaceuticals
INO
#8709
Rank
S$0.31 B
Marketcap
S$1.86
Share price
-3.97%
Change (1 day)
-33.67%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -S$0.11 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.12 Billion, an increase over its 2024 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.11 Billion-7.79%
2025 -S$0.12 Billion-16.07%
2024 -S$0.14 Billion-20.03%
2023 -S$0.18 Billion-51.56%
2022 -S$0.36 Billion-8.26%
2021 -S$0.39 Billion95.4%
2020 -S$0.2 Billion36.62%
2019 -S$0.15 Billion20.19%
2018 -S$0.13 Billion10.94%
2017 -S$0.11 Billion9.59%
2016 -S$98.95 Million118.9%
2015 -S$45.21 Million-10.67%
2014 -S$50.6 Million83.32%
2013 -S$27.61 Million
2011 -S$28.48 Million15.64%
2010 -S$24.63 Million37.7%
2009 -S$17.89 Million2.19%
2008 -S$17.5 Million-14.09%
2007 -S$20.37 Million19.12%
2006 -S$17.1 Million9.62%
2005 -S$15.6 Million5.77%
2004 -S$14.75 Million73.08%
2003 -S$8.53 Million12.75%
2002 -S$7.56 Million
2000 -S$11.44 Million53.93%
1999 -S$7.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$23.98 B-22,845.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.19 B-15,460.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.92 B-8,565.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$3.25 Billion 2,977.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.61 B-8,268.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.16 B-8,792.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-S$3.53 Million-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA